HeatherYeckes-RodinMD

Oncology • Port St. Lucie, FL

Physician

Join to view full profile

Dr. Yeckes-Rodin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Yeckes-Rodin's full profile

Already have an account?

Office
1871 S. E. Tiffany Ave
Suite 100
Port St. Lucie, FL 34952
Phone+1 772-355-5666

Fax+1 772-335-3781
Is this information wrong?

Education & Training

Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
Massachusetts General HospitalResidency, Internal Medicine, 2001 - 2004
University of Miami Leonard M. Miller School of MedicineClass of 2001

Certifications & Licensure

MA State Medical License 2003 - 2025
FL State Medical License 2007 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

2 citations
Phase 1/1b open-label, dose-escalation study of fruquintinib in patients with advanced solid tumors in the United States.
Andrea Wang-Gillam, William Schelman, Stacey Ukrainskyj, Caly Chien, Martha Gonzalez, Zhao Yang, Marek Kania, Heather Yeckes-Rodin> ;Investigational New Drugs. 2023 Dec 1
2 citations
Eganelisib, a First-in-Class PI3Kγ Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 Trial.
Hong, D., Postow, M., Chmielowski, B., Sullivan, R., Patnaik, A., Cohen, E., Shapiro, G., Steuer, C., Gutierrez, M., Yeckes-Rodin, H., Ilaria, R., O'Connell, B., Peng,...> ;Clinical Cancer Research. 2023 Jun 13
19 citations
Bortezomib treatment causes remission in a Ph+ALL patient and reveals FoxO as a theranostic marker
Rajan Dewar, Sing Tsung Chen, Heather Yeckes-Rodin, Kenneth B. Miller, Roya Khosravi-Far> ;Cancer Biology & Therapy. 2011 Mar 15
Proteasome inhibition causes regression of leukemia and abrogates BCR-ABL-induced evasion of apoptosis in part through regulation of forkhead tumor suppressors.
Jagani, Z., Song, K., Kutok, J. L., Dewar, M. R., Melet, A., Santos, T., Grassian, A., Ghaffari, S., Wu, C., Yeckes-Rodin, H., Rodin, H. Y., Ren, R., Miller, K., Khosr...> ;Cancer Res. 2009 Aug 15
Join now to see all

Professional Memberships

American College of Physicians - ACP
Member

Hospital Affiliations

HCA Florida Lawnwood HospitalFort Pierce, Florida
Cleveland Clinic Martin North HospitalStuart, Florida
Port St. Lucie HospitalPort St. Lucie, Florida